130 related articles for article (PubMed ID: 12739139)
41. Germline gain-of-function mutations in SOS1 cause Noonan syndrome.
Roberts AE; Araki T; Swanson KD; Montgomery KT; Schiripo TA; Joshi VA; Li L; Yassin Y; Tamburino AM; Neel BG; Kucherlapati RS
Nat Genet; 2007 Jan; 39(1):70-4. PubMed ID: 17143285
[TBL] [Abstract][Full Text] [Related]
42. PTPN11 mutations play a minor role in isolated congenital heart disease.
Weismann CG; Hager A; Kaemmerer H; Maslen CL; Morris CD; Schranz D; Kreuder J; Gelb BD
Am J Med Genet A; 2005 Jul; 136(2):146-51. PubMed ID: 15940693
[TBL] [Abstract][Full Text] [Related]
43. [Noonan's syndrome caused by a mutation in the PTPN11 gene].
Lloreda-García JM; Martínez-Aedo MJ; Tarttaglia M; López-Siguero JP
An Pediatr (Barc); 2006 Dec; 65(6):635-6. PubMed ID: 17194341
[No Abstract] [Full Text] [Related]
44. [Noonan syndrome].
Ogata T
Nihon Rinsho; 2006 Jun; Suppl 2():505-10. PubMed ID: 16817452
[No Abstract] [Full Text] [Related]
45. Acute lymphoblastic leukaemia in Noonan syndrome.
Roti G; La Starza R; Ballanti S; Crescenzi B; Romoli S; Foá R; Tartaglia M; Aversa F; Fabrizio Martelli M; Mecucci C
Br J Haematol; 2006 May; 133(4):448-50. PubMed ID: 16643459
[No Abstract] [Full Text] [Related]
46. Does the rare A172G mutation of PTPN11 gene convey a mild Noonan syndrome phenotype?
Kitsiou-Tzeli S; Papadopoulou A; Kanaka-Gantenbein C; Fretzayas A; Daskalopoulos D; Kanavakis E; Nicolaidou P
Horm Res; 2006; 66(3):124-31. PubMed ID: 16804314
[TBL] [Abstract][Full Text] [Related]
47. Mediating ERK 1/2 signaling rescues congenital heart defects in a mouse model of Noonan syndrome.
Nakamura T; Colbert M; Krenz M; Molkentin JD; Hahn HS; Dorn GW; Robbins J
J Clin Invest; 2007 Aug; 117(8):2123-32. PubMed ID: 17641779
[TBL] [Abstract][Full Text] [Related]
48. Aortic root dilatation is a rare complication of Noonan syndrome.
Power PD; Lewin MB; Hannibal MC; Glass IA
Pediatr Cardiol; 2006; 27(4):478-80. PubMed ID: 16830086
[TBL] [Abstract][Full Text] [Related]
49. Clonal duplication of a germline PTPN11 mutation due to acquired uniparental disomy in acute lymphoblastic leukemia blasts from a patient with Noonan syndrome.
Karow A; Steinemann D; Göhring G; Hasle H; Greiner J; Harila-Saari A; Flotho C; Zenker M; Schlegelberger B; Niemeyer CM; Kratz CP
Leukemia; 2007 Jun; 21(6):1303-5. PubMed ID: 17361219
[No Abstract] [Full Text] [Related]
50. Noonan syndrome: relationships between genotype, growth, and growth factors.
Limal JM; Parfait B; Cabrol S; Bonnet D; Leheup B; Lyonnet S; Vidaud M; Le Bouc Y
J Clin Endocrinol Metab; 2006 Jan; 91(1):300-6. PubMed ID: 16263833
[TBL] [Abstract][Full Text] [Related]
51. PTPN11 (protein tyrosine phosphatase, nonreceptor type 11) mutations and response to growth hormone therapy in children with Noonan syndrome.
Ferreira LV; Souza SA; Arnhold IJ; Mendonca BB; Jorge AA
J Clin Endocrinol Metab; 2005 Sep; 90(9):5156-60. PubMed ID: 15956085
[TBL] [Abstract][Full Text] [Related]
52. Mutational analysis of the PTPN11 gene in Egyptian patients with Noonan syndrome.
Essawi ML; Ismail MF; Afifi HH; Kobesiy MM; El Kotoury A; Barakat MM
J Formos Med Assoc; 2013 Nov; 112(11):707-12. PubMed ID: 24183200
[TBL] [Abstract][Full Text] [Related]
53. PTPN11 is the first identified proto-oncogene that encodes a tyrosine phosphatase.
Chan RJ; Feng GS
Blood; 2007 Feb; 109(3):862-7. PubMed ID: 17053061
[TBL] [Abstract][Full Text] [Related]
54. Germline gain-of-function mutations in RAF1 cause Noonan syndrome.
Razzaque MA; Nishizawa T; Komoike Y; Yagi H; Furutani M; Amo R; Kamisago M; Momma K; Katayama H; Nakagawa M; Fujiwara Y; Matsushima M; Mizuno K; Tokuyama M; Hirota H; Muneuchi J; Higashinakagawa T; Matsuoka R
Nat Genet; 2007 Aug; 39(8):1013-7. PubMed ID: 17603482
[TBL] [Abstract][Full Text] [Related]
55. PTPN11 gene analysis in 74 Brazilian patients with Noonan syndrome or Noonan-like phenotype.
Bertola DR; Pereira AC; Albano LM; De Oliveira PS; Kim CA; Krieger JE
Genet Test; 2006; 10(3):186-91. PubMed ID: 17020470
[TBL] [Abstract][Full Text] [Related]
56. Respiratory failure, juvenile myelomonocytic leukemia, and neonatal Noonan syndrome.
Cheong JL; Moorkamp MH
J Pediatr Hematol Oncol; 2007 Apr; 29(4):262-4. PubMed ID: 17414570
[TBL] [Abstract][Full Text] [Related]
57. A novel PTPN11 gene mutation bridges Noonan syndrome, multiple lentigines/LEOPARD syndrome and Noonan-like/multiple giant cell lesion syndrome.
Sarkozy A; Obregon MG; Conti E; Esposito G; Mingarelli R; Pizzuti A; Dallapiccola B
Eur J Hum Genet; 2004 Dec; 12(12):1069-72. PubMed ID: 15470362
[TBL] [Abstract][Full Text] [Related]
58. Diverse biochemical properties of Shp2 mutants. Implications for disease phenotypes.
Keilhack H; David FS; McGregor M; Cantley LC; Neel BG
J Biol Chem; 2005 Sep; 280(35):30984-93. PubMed ID: 15987685
[TBL] [Abstract][Full Text] [Related]
59. Noonan-like/multiple giant cell lesion syndrome: report of a case and review of the literature.
Wolvius EB; de Lange J; Smeets EE; van der Wal KG; van den Akker HP
J Oral Maxillofac Surg; 2006 Aug; 64(8):1289-92. PubMed ID: 16860226
[No Abstract] [Full Text] [Related]
60. BIAcore analysis to test phosphopeptide-SH2 domain interactions.
Vély F; Trautmann A; Vivier E
Methods Mol Biol; 2000; 121():313-21. PubMed ID: 10818737
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
